SVP - US Medical Affairs

Position Summary

The SVP US Medical Affairs (USMA) reports to the Chief Executive Officer of Genentech. This is a key role for the Company that will be based in South San Francisco.

USMA is an independent division of Genentech with full accountability for its own strategy. The Head of USMA is a member of and actively participates in the Affiliate Pharma Executive Team (USLT and MLT), the global Medical Affairs Committee (MAC), the global Medical Compliance Committee (MCC), the US Promotional Review Committee (PRC) and the US Healthcare Compliance Committee (HCC).

The SVP USMA will lead, motivate, coach, and lead the Medical Affairs Department in Genentech to meet all Company (Roche and Genentech) scientific, ethical, regulatory, compliance, and business objectives. This person will build and lead a highly functioning and effective team to rebrand the medical role at Genentech with key customers and patients as well as external stakeholders and thought leaders. In addition, this person will direct and deploy the company's efforts, focus, and attention to the right KOLs, enhance MSL engagement, evidence generation, and close gaps by working with the clinical study sites. The SVP will expand patient reach by overcoming the barriers necessary to ensure the right patients receive the right medicines, setting up medicines for success and driving mass market entries.

This person will be expected to lead a team of 530 FTEs across all medical affairs functions, including, but not limited to, Therapeutic Area Head Medical Affairs Leads (Oncology/Hematology, Neurology/Ophthalmology/Pipeline, Immunology, and Cardiovascular Renal & Metabolism), Field Medical, Medical Operations, (including writing, information and education), and Business Strategy & Operations.

This role will contribute to medical excellence globally and ensure compliance with Good Clinical Practices (GCP) and Good Pharmacovigilance Practices (GVP) in the North American region (Genentech and Roche Canada).

This role, like all others at Roche and Genentech, is expected to demonstrate the Roche Operating Principles: 

• Put Patients First: I always act as if patients I know are in the room and do what's best for them. 

• Follow the science: I seek answers through experiments, data and debate, and act on facts. 

• Act as one team: I care, collaborate and commit without boundaries, and trust others to do their part. 

• Embrace differences: I seek diverse perspectives, invite opposing views, and challenge myself, and others. 

• Accelerate learning: I push to learn new things even if difficult, and openly share my successes and failures. 

• Simplify radically: I eliminate complexity, reuse with pride, and accomplish more with less. 

• Make impact now: I take accountability to do what is right, deliver value fast, and don't wait for certainty. 

• Think long term: I choose actions today that benefit future generations.

Year One Priorities

While the above represents the scope of the role on an ongoing basis, the SVP USMA is expected to make significant progress on the below areas within the first 12 months of their tenure. They are not listed in any particular order of significance.

• Energize MA by building a highly effective team that functions at optimal levels 

• Rebrand the SVP MA role and function to emphasize customers and patients 

• Integrate Clinical Operations and R&D across key groups within the Medical Affairs organization 

• Deploy focus strategically to close gaps, understanding where to place effort and attention in areas such as evidence generation, MSL engagement, and work with the study sites 

• Expand to support new medicines getting to the right patients and overcoming barriers to reach patients 

• Set up new therapies and medicines for success 

• Demonstrate strong familiarity with the Roche/Genentech development pipeline and with existing therapies 

• Establish credibility within the USLT (and other leadership teams across Genentech/Roche), building relationships as an enterprise thinker who is "all in" and can drive change 

• Maintain, build, and strengthen relationships with external thought leaders and KOLs

•  Establish effective interaction between USMA and other Roche/Genentech functions; and with